We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Ascendis Pharma A/S
ASND
$16.7B
| $5.13M | 0.01% |
+24,079
| New | +$4.97M |
|
1327
HDFC Bank
HDB
$120B
| $5.12M | 0.01% |
140,075
+122,133
| +681% | +$4.39M |
|
|
TEM
1328
Tempus AI
TEM
$10B
| $5.11M | 0.01% |
86,600
+74,921
| +642% | +$5.86M |
|
1329
UWM Holdings
UWMC
$2.45B
| $5.11M | 0.01% |
1,166,753
-2,770,810
| -70% | -$14.9M |
|
|
DOO
1330
Bombardier Recreational Products
DOO
$4.79B
| $5.11M | 0.01% |
72,205
+54,714
| +313% | +$3.73M |
|
1331
Alector
ALEC
$233M
| $5.09M | 0.01% |
+3,265,575
| New | +$5.79M |
|
1332
Boise Cascade
BCC
$2.98B
| $5.07M | 0.01% |
68,888
+7,433
| +12% | +$542K |
|
1333
PUT
SoFi Technologies
SOFI
$23.2B
| $5.07M | 0.01% |
193,500
+172,900
| +839% | +$4.82M |
|
1334
PUT
iShares Biotechnology ETF
IBB
$9.81B
| $5.06M | 0.01% |
+30,000
| New | +$4.87M |
|
1335
Evolent Health
EVH
$464M
| $5.04M | 0.01% |
1,261,007
+1,086,461
| +622% | +$6.04M |
|
1336
Avient
AVNT
$4.17B
| $5.04M | 0.01% |
161,179
+101,341
| +169% | +$3.14M |
|
|
OKLO
1337
Oklo
OKLO
$8.74B
| $5.02M | 0.01% |
69,990
+67,529
| +2,744% | +$7.53M |
|
1338
Dole
DOLE
$1.22B
| $5.02M | 0.01% |
334,569
-478,202
| -59% | -$6.66M |
|
|
ARI
1339
Apollo Commercial Real Estate
ARI
$862M
| $5.01M | 0.01% |
517,928
+128,362
| +33% | +$1.28M |
|
1340
CALL
HP
HPQ
$26.6B
| $5M | 0.01% |
+224,400
| New | +$5.72M |
|
1341
iShares MSCI Saudi Arabia ETF
KSA
$623M
| $4.99M | 0.01% |
137,137
+33,493
| +32% | +$1.3M |
|
1342
UGI
UGI
$7.54B
| $4.99M | 0.01% |
133,250
-338,070
| -72% | -$12M |
|
1343
ProShares Short QQQ
PSQ
$647M
| $4.96M | 0.01% |
+164,258
| New | +$5.01M |
|
|
LAC
1344
Lithium Americas
LAC
$1.18B
| $4.96M | 0.01% |
+1,137,246
| New | +$6.57M |
|
1345
AGNC Investment
AGNC
$12.9B
| $4.95M | 0.01% |
+461,636
| New | +$4.75M |
|
|
SEI
1346
PUT
Solaris Energy Infrastructure
SEI
$3.87B
| $4.94M | 0.01% |
+107,500
| New | +$5.2M |
|
1347
Denison Mines
DNN
$3B
| $4.94M | 0.01% |
+1,856,293
| New | +$5.05M |
|
1348
CALL
Abercrombie & Fitch
ANF
$5.24B
| $4.93M | 0.01% |
+39,200
| New | +$3.43M |
|
1349
Thermo Fisher Scientific
TMO
$224B
| $4.93M | 0.01% |
+8,504
| New | +$4.81M |
|
1350
CALL
McDonald's
MCD
$194B
| $4.92M | 0.01% |
16,100
+14,200
| +747% | +$4.35M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.